Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 3
1982 3
1983 4
1984 2
1985 6
1986 6
1987 7
1988 9
1989 7
1990 6
1991 3
1992 3
1993 2
1994 7
1995 5
1996 7
1997 9
1998 13
1999 9
2000 13
2001 10
2002 5
2003 7
2004 13
2005 6
2006 3
2007 6
2008 11
2009 8
2010 13
2011 7
2012 3
2013 8
2014 5
2015 9
2016 13
2017 10
2018 9
2019 4
2020 7
2021 11
2022 6
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

291 results

Results by year

Filters applied: . Clear all
Page 1
Macrophages as tools and targets in cancer therapy.
Mantovani A, Allavena P, Marchesi F, Garlanda C. Mantovani A, et al. Among authors: allavena p. Nat Rev Drug Discov. 2022 Nov;21(11):799-820. doi: 10.1038/s41573-022-00520-5. Epub 2022 Aug 16. Nat Rev Drug Discov. 2022. PMID: 35974096 Free PMC article. Review.
Cancer-related inflammation.
Mantovani A, Allavena P, Sica A, Balkwill F. Mantovani A, et al. Among authors: allavena p. Nature. 2008 Jul 24;454(7203):436-44. doi: 10.1038/nature07205. Nature. 2008. PMID: 18650914 Free article. Review.
Tumour-associated macrophages as treatment targets in oncology.
Mantovani A, Marchesi F, Malesci A, Laghi L, Allavena P. Mantovani A, et al. Among authors: allavena p. Nat Rev Clin Oncol. 2017 Jul;14(7):399-416. doi: 10.1038/nrclinonc.2016.217. Epub 2017 Jan 24. Nat Rev Clin Oncol. 2017. PMID: 28117416 Free PMC article. Review.
Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity.
Anfray C, Mainini F, Digifico E, Maeda A, Sironi M, Erreni M, Anselmo A, Ummarino A, Gandoy S, Expósito F, Redrado M, Serrano D, Calvo A, Martens M, Bravo S, Mantovani A, Allavena P, Andón FT. Anfray C, et al. Among authors: allavena p. J Immunother Cancer. 2021 Sep;9(9):e002408. doi: 10.1136/jitc-2021-002408. J Immunother Cancer. 2021. PMID: 34531246 Free PMC article.
Targeting tumour-associated macrophages.
Sica A, Rubino L, Mancino A, Larghi P, Porta C, Rimoldi M, Solinas G, Locati M, Allavena P, Mantovani A. Sica A, et al. Among authors: allavena p. Expert Opin Ther Targets. 2007 Sep;11(9):1219-29. doi: 10.1517/14728222.11.9.1219. Expert Opin Ther Targets. 2007. PMID: 17845147 Review.
Inflammation as target in cancer therapy.
Marelli G, Sica A, Vannucci L, Allavena P. Marelli G, et al. Among authors: allavena p. Curr Opin Pharmacol. 2017 Aug;35:57-65. doi: 10.1016/j.coph.2017.05.007. Epub 2017 Jun 12. Curr Opin Pharmacol. 2017. PMID: 28618326 Review.
Tumor-associated myeloid cells: diversity and therapeutic targeting.
Mantovani A, Marchesi F, Jaillon S, Garlanda C, Allavena P. Mantovani A, et al. Among authors: allavena p. Cell Mol Immunol. 2021 Mar;18(3):566-578. doi: 10.1038/s41423-020-00613-4. Epub 2021 Jan 20. Cell Mol Immunol. 2021. PMID: 33473192 Free PMC article. Review.
Macrophage polarization in pathology.
Sica A, Erreni M, Allavena P, Porta C. Sica A, et al. Among authors: allavena p. Cell Mol Life Sci. 2015 Nov;72(21):4111-26. doi: 10.1007/s00018-015-1995-y. Epub 2015 Jul 26. Cell Mol Life Sci. 2015. PMID: 26210152 Review.
291 results